How Supplement Stores Are Trying to Tap Into the Ozempic Boomnews2024-04-29T23:03:41+00:00April 29th, 2024|The New York Times|
Senate Begins Investigation Into Ozempic and Wegovy Pricesnews2024-04-24T16:00:14+00:00April 24th, 2024|The New York Times|
How Ozempic Is Transforming a Small Danish Townnews2024-04-20T04:01:50+00:00April 20th, 2024|The New York Times|
Inside Novo Nordisk, the Company Behind Ozempic and Wegovynews2024-04-20T04:01:23+00:00April 20th, 2024|The New York Times|
Un estudiomostró que se puede frenar el párkinson con lixisenatidanews2024-04-05T16:59:42+00:00April 5th, 2024|The New York Times|
An Ozempic Relative Slowed Parkinson’s Disease in a Small Studynews2024-04-03T21:02:24+00:00April 3rd, 2024|The New York Times|
Por qué la gente odia las medicinas de por vida y por qué Ozempic sería distintonews2024-03-26T04:02:05+00:00March 26th, 2024|The New York Times|
Patients Hate ‘Forever’ Drugs. Are Ozempic and Wegovy Different?news2024-03-24T19:21:34+00:00March 24th, 2024|The New York Times|
The Race to Stop Ozempic Muscle Lossnews2024-02-08T16:37:05+00:00February 8th, 2024|The New York Times|
Users of Zepbound or Mounjaro Had Lower Blood Pressure in Studynews2024-02-05T16:10:45+00:00February 5th, 2024|The New York Times|
